Jamie Rhoads, MD
Dermatology · Murray, UTNPI 1104093392
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Lilly USA, LLC at 46.1% of the total. Among dermatology clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 95 payments — averaging $1101.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$48K
- Regeneron$32K
- Boehringer Ingelheim$14K
- Argenx US, Inc.$8K
- Eli Lilly$3K
- Johnson & Johnson$354
- plus $179 from 2 others
Across 353 payments — averaging $6822.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$867K
- Amgen$366K
- Pfizer$296K
- Regeneron$276K
- Eli Lilly$272K
- Incyte Corporation$159K
- plus $171K from 5 others
What the payments were for
- Consulting fees$50,80949%
- Speaking & faculty fees$40,90039%
- Travel & lodging$11,59111%
- Food & beverage$9611%
- Education$3540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 50 | $48,237 |
| Regeneron | 25 | $32,046 |
| Boehringer Ingelheim | 5 | $13,739 |
| Argenx US, Inc. | 5 | $7,560 |
| Eli Lilly | 1 | $2,500 |
| Johnson & Johnson | 4 | $354 |
| AbbVie | 4 | $165 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$104,615 in reported general payments places this provider in the 95th percentile of 163 dermatology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 20 | $75,947 |
| Dupixent PenDupilumab | 12 | $43,918 |
| Doxycycline Monohydrate | 39 | $3,345 |
| Clobetasol Propionate | 57 | $2,276 |
| Hydroxychloroquine Sulfate | 54 | $2,074 |
| Dapsone | 21 | $1,761 |
| Mycophenolate Mofetil | 17 | $1,347 |
| Cyclosporine ModifiedCyclosporine, Modified | 18 | $1,259 |
| Finasteride | 50 | $638 |
| Minoxidil | 51 | $524 |
| Azathioprine | 17 | $421 |
| MethotrexateMethotrexate Sodium | 12 | $279 |
| Triamcinolone Acetonide | 20 | $154 |
| Lidocaine Hcl ViscousLidocaine Hcl | 12 | $120 |
| Prednisone | 11 | $43 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Murray
- Sancy LeachmanMurray$34K
- Brian WilliamsMidvale$876K
- Travis JamesProvidence$437K
- Jason HadleyBountiful$294K
- Doug Lass ForshaWest Jordan$213K
- Gerald KruegerSalt Lake City$156K
- Kristina DuffinSalt Lake City$89K
- Mark TaylorSalt Lake City$58K
- Lori RamirezKaysville$38K
- Lindsay WilsonTaylorsville$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.